(Q33370115)

English

Phase III trial of intraperitoneal therapy with yttrium-90-labeled HMFG1 murine monoclonal antibody in patients with epithelial ovarian cancer after a surgically defined complete remission

scientific article

Statements

Phase III trial of intraperitoneal therapy with yttrium-90-labeled HMFG1 murine monoclonal antibody in patients with epithelial ovarian cancer after a surgically defined complete remission (English)
René H Verheijen
Leon F Massuger
Benedict B Benigno
Agamemnon A Epenetos
Alberto Lopes
John T Soper
Janica Markowska
Rostislav Vyzula
Gordon Stamp
Gregory Spiegel
Dennis Thurston
Michael V Seiden
1 February 2006

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit